Drug Details
Therapeutic Class:
Selective serotonin reuptake inhibitor (SSRI) and 5HT1A receptor partial agonist
Forms:
Tablet
Administration:
By mouth
Therapeutic Uses:
For the treatment of major depressive disorder
Controlled Status:
Not a controlled substance
Viibryd Drug Class
Viibryd (why-brid), generic vilazodone (vil-az-oh-done), belongs to a group of medications called serotonin modulators. It has a combination of selective serotonin reuptake inhibition and 5HT1A receptor partial agonist activity.
Viibryd Age Range
Viibryd is approved for use in people 18 years of age and above. Antidepressants increase the risk of suicidal thoughts and behaviors in pediatric patients below 18 years of age.
SOCIAL